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Bacterial ribosomes have been shown to be specific antigens in 
immunoassays. However, N. gonorrhoeae ribosomes have not been 
tested for use in a reliable immunological test for the detection 
of gonorrhea, In the present study, in vitro macrophage migration 
inhibition (MIF) tests were employed to characterize the cell-
mediated immune (CMI) response of gonorrhea patients to a crude 
gonococcal ribosome preparation. It was ascertained that lymph­
ocytes from patients had become sensitized to homologous ribosomes 
within 10 days of contact of the disease and lose sensitization 
8 to 16 weeks post-therapy. A similar but non-specific response 
was observed with lymphocytes from patients and control subjects, 
when incubated with gonococcal endotoxin. Differential criteria 
for diagnosis were established according to lymphocyte responses 
to the two preparations, and were used in correct diagnosis of 7 
of 9 culture-positive patients and 8 of 9 negative controls. Re­
sults from this research warrant the investigation of chimpanzee 
or human infection for vivo responses to intradermal adminis­
tration of gonococcal ribosomes. 
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CHAPTER I 
INTRODUCTION 
Gonorrhea is currently the number one reported communi­
cable disease in the United States. Yet, for every reported 
case it is estimated that there are three cases which go un­
reported (2). The primary reason for this is that gonorrhea 
is commonly without symptoms. Estimates of asymptomatic 
female infection range from 40% to 80%, and estimates of 
asymptomatic male infection range from 5% to 50% (32, 55). 
Without symptoms of infection, infected persons do not seek 
diagnosis, and therefore comprise a pool or reservoir of 
infection in the population which helps maintain the disease 
at epidemic proportions (12, 52), Despite adequate treatment 
procedures, reported cases of gonorrhea doubled in the six 
years from 1966-1972, with 624,000 cases reported in the U.S. 
in 1971 (10). The need is apparent for a means by which this 
epidemic may be controlled. 
Researchers have studied the possibility of developing 
a protective vaccine against Neisseria gonorrhoeae infection. 
Arko (4, 5) was able to establish a protective immunity in 
chimpanzees with a formalinized whole-cell vaccine; protec­
tion lasted ten weeks. Others have stimulated increased 
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antibody levels by vaccination, without evident protective 
effects (30), although Drutz (24) has reported that patients 
with a history of gonococcal infection are more difficult to 
infect experimentally. Recent reports indicate that gonococ­
cal ribosomes provide an effective vaccine, which stimulated 
inhibition of N. gonorrhoeae growth in subcutaneous chambers 
implanted in guinea pigs (16). Although development of a 
vaccine would be ideal in dealing with the epidemic, endeav­
ors to date have revealed less than desirable results. The 
major barrier to developing a vaccine is lack of a gonococ­
cal antigen which will elicit a protective response and will 
continue to elicit that response for long periods of time. 
Investigations to date have been able to do no better than 
mimic the natural infection which, because it is localized 
and somewhat isolated from the immune system, elicits an 
antibody response that lasts for only a few months post-
therapy and fails to elicit a detectable protective immunity 
( 3 8 ) ,  
Therefore, investigators have focused on an approach to 
screen large populations in order to detect and treat this 
pool of infection. Diagnosis is presently based on the abil­
ity to culture N. gonorrhoeae organisms from the vagina or 
male urethra. In 1973 a gonococcal culture screening pro­
gram was employed by the United States Public Health Service 
in an attempt to identify the reservoir of infection in the 
population (2). The program detected 242,276 positives from 
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nearly 5 million examined in 1973, or approximately 5 per 
cent. Though seemingly significant, this segment of the 
population examined represents a very small fraction of the 
total population at risk. The method of culturing is suffi­
cient for laboratory diagnosis (70-90% reliable) (14, 55, 58, 
72), but is time consuming and expensive for application in 
a large scale screening program. 
Epidemiologically, a system of 5 to 8 minute interviews 
with culture-positive patients, in order to identify sexual 
partners, has detected many asymptomatic victims (10, 55), 
Such methods are expensive, time consuming, and inefficient 
at locating the partners. Therefore, this approach is im­
practical as a single screening tool, although useful as an 
adjunct. 
In the search for reliable and easily administered di­
agnostic tests, researchers have turned to examination of 
patients' immune response. Studies have focused primarily 
on the humoral (circulating antibody) response, with various 
gonococcal preparations used as antigens. Complement fixa­
tion tests using N. gonorrhoeae protoplasm and protoplasm 
fractionated through Sephadex as antigens have detected 
higher serum antibody levels in patients than in controls 
(20, 38, 64, 68, 86). Gel immunodiffusion (13), micropreci-
pitin (15, 67), and micro-flocculation with gonococcal ex­
tracts adhered to cholesterol-lecithin particles (66) have 
been studied. These tests lack specificity and sensitivity. 
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yielding a high percentage of false positive and false nega­
tive diagnoses. Radioimmunoassay with pilin and partially 
defined cellular preparations used as antigens, has been the 
most sensitive method examined to date (38, 53). These re­
quire simplification of technique and adaptation to equipment 
commonly available in clinical diagnostic laboratories, be­
fore being employed as a tool to screen for the pool of 
asymptomatic infections. 
Cell-mediated immunity (CMI) or delayed hypersensiti­
vity has been shown be David et aj^. (21, 22, 23) to be as 
specific as humoral immunity in non-gonococcal systems. 
With ̂  vitro and ̂  vivo methodologies of delayed hypersen­
sitivity, he demonstrated no cross reactivity to antigens 
with animals sensitized to PPD, ovalbumin, and toxoid. Thor 
et al. (82) found similar specificity with PPD, histoplasmin, 
and coccidioidin. Such specificity of delayed hypersensi­
tivity is the basis for tuberculosis skin test diagnosis. 
Examination of CMI to gonococcal infection has received 
much less consideration than has humoral testing. In 
studies carried out early in this century, various gonococcal 
extracts were employed as antigens in skin tests on patients. 
Whole cells, autolysis extracts, and other N. gonorrhoeae 
culture filtrates revealed cutaneous induration 24 h follow­
ing injection (17, 35, 40, 47). These tests were abandoned 
with the inception and widespread use of penicillin treat­
ment. 
Hot until the 1970's did investigators resume study of 
CMI in gonococcal patients. Kraus et a2. (49) used a lyo-
philized gonococcal sonicate as antigen and demonstrated CMI 
by dm vitro blastogenesis of lymphocytes taken from men with 
repeated gonococcal urethritis. These studies failed to 
show significant differences in blastogenesis between con­
trols and patients having had only one infection. Grimble 
and Mclllmurray (31) in 1973 found 86% positive CMI response 
in vitro by patients' lymphocytes to a cell sonicate super­
natant fluid (protoplasm). They found that lymphocytes 
became reactive within 4 to 5 days after contraction of in­
fection. Lymphocytes from patients did not respond to simi­
lar antigen preparations from the closely related Neisseria 
meningitidis organism. Esquenazi and Streitfeld (26, 27) 
found in both the rabbit and human system that vitro 
lymphocyte blastogenesis to various protoplasmic fractions 
disappeared 5 to 6 weeks after vaccination (rabbit) or treat­
ment (human). 
Most humoral and CMI immunological tests lack an anti­
gen which is specific to N. gonorrhoeae. The antigen used 
must be one to which infected persons are sensitive, and 
which does not cross react with persons sensitive to closely 
related organisms. Present evidence indicates that ribosoities 
of each species of bacteria are antigenically specific for 
that organism (18, 59, 61). Otaka et (60) found the 30S 
ribosomal subunits of Escherichia coli strains K12 and B to 
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differ in one or more ribosomal proteins. Their work demon­
strated that some ribosomal proteins from 2 strains of the 
same species are electrophoretically identical, yet some are 
different. Alberghina and Suskind (1) found that animals 
immunized with Neurospora crassa responded by making anti­
bodies which precipitated N. crassa ribosomes. Sarkar and 
Som (69) immunized rabbits with ribosomal protein of plant, 
rat, E. coli, and yeast, and found reactions with immuno­
diffusion tests only with homologous ribosomal protein. 
Judd and Koostra (44, 48) using various cell wall, pilin, 
protoplasmic, and ribosomal preparations (crude ribosomes, 
50S, 30S, ribosomal RNA, and ribosomal protein) demonstrated 
CMI in guinea pigs sensitized by whole cell N. gonorrhoeae 
vaccinations. They found that crude ribosomes were specific 
for guinea pigs sensitized to the homologous organisms, and 
minimal cross reactivity with ribosomes from closely related 
N. meningitidis organisms. 
Other investigators have used ribosomes as immunogens 
to vaccinate animals against various microorganisms of 
tumors. These studies demonstrated that ribosomes are immu­
nogenic. Zatti ̂  aA. (94) were able to protect rats from 
Yoshida ascites tumor by injection of homologous ribosomes. 
Similar protective immunity has been demonstrated in experi­
mental animals against Streptococcus pyogenes (70), Staphy­
lococcus aureus (87, 88), Diplococcus pneumoniae (79), N-
gonorrhoeae (16), Mycobacterium tuberculosis (90, 91, 92, 
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93), and Salmonella typhimurium (39, 43, 63, 84). Johnson 
(4 3) found that the protection afforded mice against Salmon­
ella typhimurium was specific; i-.e., it did not provide pro­
tection against challenge with Salmonella enteritidis or 
Salmonella cholerae-suis. 
Ribosomes may be immunogens, antigens to detect humoral 
immunity, and antigens involved in CMI. Baker et (6, 7) 
demonstrated CMI induced in rabbits to BCG crude ribosomes 
and a "30S-50S" pool of BCG ribosomes by skin testing, MIF 
testing, and skin reactive factor testing. Smith and Bigley 
(73, 74) demonstrated that ribosomal immunization would pro­
tect mice from 5000 of Salmonella typhimurium. This 
protection was transferred to normal mice by peritoneal 
exudate cells, lymph node cells, or spleen cells, but not by 
serum. Judd and Koostra (44, 48), as mentioned above, dem­
onstrated CMI to N. gonorrhoeae ribosomes in sensitized 
guinea pigs, and showed a correlation between ̂  vitro macro­
phage migration inhibition (MIF) tests of CMI and vivo 
skin testing. 
Lipopolysaccharide (LPS) from gram-negative bacteria 
has shown to cause lymphocytes to mimic CMI (33, 34, 62, 75). 
These investigators have demonstrated that LPS may inhibit 
cell migration in MIF tests, or stimulate blastogenesis in 
in vitro lymphocyte transformation tests. This has opened 
a major criticism of ribosomal immunology since ribosomal 
preparations from gram-negative bacteria almost certainly 
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are contaminated with LPS during their isolation. Therefore, 
LPS contained withing ribosomal preparations may be respon­
sible for results obtained (53). 
Many ̂  vitro correlates of skin test CMI have been 
developed (9, 29, 45, 80, 81, 82, 89). Most of these measure 
lymphokine release from sensitive lymphocytes upon exposure 
to antigens. David et aJ^. (22) discovered that guinea pig 
macrophages, when incubated with sensitive lymphoytes, were 
inhibited from migrating upon exposure to antigen. Perito­
neal exudate (PE) cells from non-sensitive guinea pigs mixed 
in a ratio of 9:1 with PE cells from sensitive guinea pigs 
produced positive MIF test results. Lymphokines released 
from the sensitive lymphocytes when exposed to antigen, inhi­
bited the non-sensitive PE cells from migrating. However, 
these non-sensitive PE cells, when incubated with sera from 
immunized animals, were not inhibited from migrating. There­
fore, CMI is responsible for this phenomenon. 
The work of David et a^. (22) presented a method by 
which delayed hypersensitivity may be studied ̂  vitro with 
human lymphocytes. Guinea pig macrophages may be mixed with 
human peripheral lymphocytes in order to perform MIF tests. 
If the human lymphocytes are sensitive to the antigen, they 
will release MIF to inhibit the guinea pig macrophages from 
migrating. 
Since LPS within ribosomal preparations may cause lym­
phocytes to mimic CMI in vitro, it is necessary to compare 
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responses to LPS and ribosomes. This will determine whether 
results from ribosomal preparations as antigen are due to 
the ribosomes, and/or to LPS contained within. 
Statement of Thesis 
Gonorrhea patients have been shown to elicit CMI to 
various partially defined antigen preparations. Homologous 
bacterial ribosomes have been used as antigens to demon­
strate CMI in many non-gonococcal infections. Previously, 
no studies had been carried out to test whether gonococcal 
patients develop CMI to N. gonorrhoeae ribosomes during the 
course of infection. Therefore, the purpose of this inves­
tigation was to: 1) determine whether patients, who are 
gonococcal culture positive, develop CMI to a N. gonorrhoeae 
ribosome preparation, and 2) characterize the moment of 
inception, and duration after drug therapy, of sensitization. 
CHAPTER II 
MATERIALS AND METHODS 
Cultivation of Neisseria gonorrhoeae 
GC Medium Base (76): In a 2 liter flat bottom flask (which 
provided large surface to volume ratio) the following sub­
stances were mixed with one liter of distilled water and 
the solution was sterilized by autoclaving: 
Proteose peptone #3 15 gm 
Corn starch 0.1 gm 
K^HPO^ 4 gm 
NaHgPO^ 1 gm 
NaCl 5 gm 
GC Supplement : The following substances were dissolved in 
100 ml of distilled water and the solution was sterilized by 
filtration through a 0.45 wg Millipore filter; 
Cocarboxylase 1 mg 
Glutamine 0.5 gm 
Glucose 20 gm 
Modified Thayer-Martin (T-M) Broth : Twenty ml of GC Supple­
ment were added to one liter of sterile GC Medium Base. The 
T-M Broth was incubated at 37°C for 48 h to insure sterility. 
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Modified T-M Chocolate Agar : Double strength CG Medium Base 
was prepared in 500 ml distilled water. Ten g of agar were 
added, and the mixture was sterilized by autoclaving. 
Ten g of hemoglobin (Ditco) were mixed in 500 ml distil­
led water and the solution was sterilized by autoclaving. 
When the sterilized solutions had cooled to 60°C, 20 ml 
of GC Supplement were added to CG Base and agar, and the 
mixture was poured into the hemoglobin solution. The Modi­
fied T-M Chocolate Agar was swirled to mix, poured into petri 
dishes, and allowed to solidify. When the Agar was solid, 
the petri dishes were sealed with tape to retain moisture, 
and refrigerated until needed. 
Bacteria : Neisseria gonorrhoeae strain F62 was obtained 
from Dr. J. A. Rudbach, University of Montana. A stock cul­
ture was maintained on T-M Chocolate Agar at 37°C in a 
candle jar. The stock was transferred to new plates routine­
ly every 4 8 h. 
Twenty-four hour cultures of N. gonorrhoeae were washed 
from agar surfaces into sterile T-M broth. The broth was 
gassed with 5% CO2 for 30 sec and incubated at 37°C on a 
wrist action shaker for 48 h (A growth curve was performed 
on the batch of cells, and revealed that late log was reached 
at 4 8 h). Flasks proven to be pure GC by subculturing onto 
T-M agar, oxidase reaction, and gram stain, were spun at 
5900xg, 4°C for 7 min to pellet the cells. Yield from one 
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liter was approximately 5 g CG. The pellet was frozen at 
-70°C until 50 g of cells had been accumulated. 
Ribosome Preparation 
Buffers : "65S" (pH 7.4) 0.015 M MgClg 
0.01 M Tris-HCl 
0.5 M NH.Cl 
Crude Ribosome Isolation : All operations were carried out 
at 4°C. Fifty g of CG were suspended in 150 ml "65S" buffer. 
The suspension was poured over 100 ml ice and left at 4°C 
overnight to kill all GC. The killed cells were pelleted at 
700 xg, resuspended in 100 ml "65S" buffer, and disrupted at 
13,000psi in a pre-chilled Ribi Cell Fractionator (56). The 
disrupted cell suspension was centrifuged at 48,200xg for 
45 min in a Sorvall RCl-B centrifuge to remove cell wall, 
cell membrane and other particulate matter. The supernatant 
fluid was centrifuged at 176,000xg for 3 h in a Beckman 
L2-65B ultracentrifuge with a Ti 60 rotor head. The pellet 
was resuspended in 30 ml "65S" buffer overnight. The sus­
pension was centrifuged at 48,200xg to remove all particulate 
matter, and the ribosomes were pelleted again at 17 6,000xg 
for 3 h. This "washed'' pellet was resuspended in 10 ml 
"65S" overnight and the concentration was adjusted to 5 mg/ 
ml. The suspension was divided into 1 ml portions, and 
stored at -70°C until needed. 
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Purified Ribosomes: Crude ribosomes isolated as above were 
eluted through a Sephadex GlOO column at 4°C. Fractions 
with peak absorbance at 254 nm were collected, sedimentation 
coefficient values were determined, and the purified ribo­
somes preparation was stored at -70°C. 
Determination of Concentration ; Using an extinction coeffi­
cient for ribosomes at 260 nm of 145 (36), the concentration 
was assayed with a Beckman DU-2 spectrophotometer. 
Concentration = Dilution^x A260 ^ mg/ml 
Determination of Protein and RNA Content ; The ratio of ab­
sorbance at 260 nm and 280 nm is characteristically 1.0 for 
ribosomes (79). All preparations used in this study had 
ratios ± 4% of that figure. 
Determination of Sedimentation Coefficient (S): A ribosomal 
preparation of 5 mg/ml was centrifuged at 260,000xg (60,000 
RPM) in a Beckman Model E ultracentrifuge. Temperature of 
the An-D rotor was maintained at 4°C, and the density gradi­
ent in the centrifuge cell was monitored every 2 min with 
photographs of the schlieren optics. The distance of the 
schlieren peak from the reference hole was measured, analyzed 
in a Wang computer with a pre-written sedimentation coeffi­
cient program, and apparent sedimentation coefficients were 
determined for each peak. Any baseline perturbation and 
peaks other than 30S, 50S, and 7 0S were indicators of the 
impurity of the preparation. 
Lipopolysaccharide (LPS) Preparation 
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Ten g of frozen GC cells were resuspended in 100 ml of 
distilled water. An equal volume of 88% phenol was added 
and the suspension was stirred at 65°C for 30 min. This 
suspension was poured into centrifuge tubes and stored at 
4°C for 3 days. The tubes were centrifuged at 1600xg, 4°C 
for 1 h and the phenol phase was discarded. The aqueous 
phase was dialyzed against running tap water at room tempera­
ture for 7 days, dialyzed at 4°C against deionized distilled 
water through three changes of water (every 3 h), lyophiD-
ized, then stored at -70°C. The lyophilized LPS was resus­
pended to 5 mg/ral in "55S" buffer and stored at -70°C until 
needed. 
Bioassays 
Limulus Assay for LPS (25, 65) : Ten-fold dilutions of E. coli 
LPS, GC LPS, and GC crude ribosomes were made with triple-
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distilled water, in dilutions of 10 ng/ml through 0.1 ng/ml. 
Limulus amebocyte lysate (LAL) was obtained from Rocky 
Mountain Laboratory, Hamilton, Montana. One-tenth ml limulus 
lysate was added to 0.1 ml of the dilution being tested, 
mixed with a Vortex mixer in 10 x 7 5 mm glass pyrogen-free 
test tubes, covered with aluminum foil, and incubated in a 
37°C waterbath for 60 min. Tubes were removed, inverted, and 
interpreted as positive if the test sample plus LAL clotted 
and did not run down the side of the tube when it was inverted. 
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I assisted with the Chick Embryo LD^q  and pyrogen as­
says, as they were performed at the Rocky Mountain Laboratory 
in Hamilton, Montana by Dr. K. C. Milner and Robert Pfeifer. 
Chick Embryo Assay for LPS (28): GC LPS and GC crude 
ribosomes diluted in sterile physiological saline were in­
jected in 0.1 ml volumes intravenously (i.v.) into 11-day 
old chick embryos which had been incubated in a humidified 
incubator at 37°C. They were observed daily by candling for 
3 days post-inoculation. Intravenous inoculation was per­
formed into a prominent allantoic vein through a 2 x 5 mm 
window in the shell. The window was made using a hand drill 
fitted with two abrasive discs separated by 2 mm; the shell 
flap was then lifted off with an 18 gauge needle. Inocula­
tions were performed while candling, using a tuberculin 
syringe and 2 7 gauge needle. 
Following inoculation, the eggs were returned to the 
incubator and examined as mentioned above for dead embryos. 
Ten eggs were used for each dilution. LD^^ values were cal­
culated by the method of Irwin and Cheeseman (41). 
Pyrogen Tests for LPS (4 6); GC LPS and GC crude ribosomes 
diluted in sterile saline were injected in 2 ml volumes into 
the marginal ear vein of rabbits weighing 2 to 3 kg. Temp­
eratures were taken by rectally implanted copper-constantan 
thermocouples and recorded automatically every 12 min with a 
Honeywell Multipoint Recorder for 6 h. Six rabbits used for 
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each dilution were acclimatized to the test area and rectal 
thermometers for 1 h before injection. 
Febrile responses were plotted on 1 x 1 inch graph paper 
with 1°C and one hour equaling 1 inch. Area under the curve 
was measured in square centimeters, and Fever Index 40 (the 
minimal dose necessary to produce an area under the curve of 
2 40 cm ) was calculated by the method of Keene et a^. (46) . 
In Vitro Studies of CMI 
Patients ; Ten ml peripheral blood samples were drawn from 
persons diagnosed as positive by GC cultivation. The blood 
was transferred to sterile heparinized (30 units/ml blood) 
test tubes, and kept at 4°C until transported to the labora­
tory. All samples were collected from the University of 
Montana Student Health Service and the Missoula City-County 
Health Department by laboratory technicians employed there. 
A coded system was employed to assure anonymity of subjects 
beyond confines of the Health Service or Health Department. 
Medical histories, where relevant, were provided under the 
coding system. 
Controls : Graduate students, professors, and employees of 
the Microbiology Department at the University of Montana were 
assumed gonococcal negative and with no history of infection 
based on their word (An assumption which many investigators 
may consider invalid). Ten ml peripheral blood samples were 
17 
drawn by Dr. W. L. Koostra or Bonna Graham, and treated the 
same as was positive blood. 
BCG+: Persons vaccinated with BCG at any time in their life 
were bled and the blood was treated as above. 
Media and Reagents ; Physiological Saline - 0.85% NaCl was 
made in distilled water, sterilized by autoclaving and stored 
at 4°C. 
Methylcellulose - Methylcellulose (Mallinckrodt, St. 
Louis; 1% = 15 centipoise) was added to distilled water and 
stored at 4°C. 
ACEP (Ammonium Cloride, EDTA, Phosphate) -
NH^Cl 0.8% 
EDTA 0.1% 
KH^PO. 0.01% 
was mixed in distilled water and the mixture was stored at 
4°C. 
MEM (Minimal Essential Medium) -
MEM (Gibco) 0.96% 
NaHCO- 0.15% 
was made in distilled water and filter sterilized. One ml of 
Penicillin (100 units/ml) plus Streptomycin (100 yg/ml) was 
added to each liter of MEM. The solution was stored at 4°C. 
Antigen dilution medium - MEM + 10% PCS (Fetal Calf 
Serum - Difco^ + 0.01 M MgCl2. 
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Pd (Dulbecco Phosphate Buffer Solution) 
NaCl 0 . 8 %  
KCl 0 . 2 %  
Ha-HPOj.VH^O 0.216% 
0 . 0 2  
was made in distilled water. The mixture was sterilized by 
autoclaving, and stored at 4°C. 
Separation of Human White Blood Cells (WBC) (Adapted from 
BjzJyum as cited in 19): Blood was diluted 3-fold with physio­
logical saline in sterile test tubes which had been treated 
with Siliclade (Clay Adams) ("siliconized"). Two ml methyl-
cellulose was added and mixed with each 10 ml of diluted 
blood. The tube was tilted to a 45 degree angle and the red 
blood cells were allowed to settle at room temperature for 
30 min. The WBC-rich supernatant portion was pipetted into 
chilled siliconized centrifuge tubes and centrifuged at 
230xg, 4°C for 10 min. The supernatant fluid was discarded 
and each cell pellet was resuspended in 2 ml ACEP. Five ml 
more ACEP was added to each tube, mixed, and incubated at 
37°C for 5 min to lyse those red blood cells remaining. 
Tubes were centrifuged again at 230xg, 4°C for 10 min 
to pellet the WBC's. The supernatant fluid was discarded 
and cells were resuspended in 1 ml MEM. Cell viability was 
ascertained on the basis of uptake of 0.4% Trypan Blue. Five 
drops of diluted cells were mixed with one drop of Trypan 
Blue and were enumerated in a hemocytometer. Cell numbers 
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were adjusted to 2 - 4 x 10^ WBC/ml in 1 ml. The WBC's were 
kept in an ice bath until needed. 
Collection of Guinea Pig Macrophages ; Normal guinea pigs 
were stimulated by intraperitoneal injection of 20 ml sterile 
mineral oil to induce increased numbers of macrophages in 
the peritoneal cavity. 
Whenever macrophages for MIF testing were needed, 
animals were sacrificed and exudate cells were washed from 
the peritoneum with 5 0 ml Pd into a chilled beaker. All 
operations from this point on were carried out on ice or at 
-4°C. The Pd was poured into a separatory funnel and the oil 
phase was discarded. The macrophage-rich Pd was centrifuged 
at 230xg for 10 min and the supernatant fluid was discarded. 
The cells were resuspended and "washed" twice in MEM. After 
the final washing the cells were resuspended in 0.4 ml MEM, 
and viability and cell counts were performed with Trypan 
Blue. 
Antigen Dilutions ; On the day of testing, a sample of ribo-
somes and a sample of LPS were allowed to thaw at room tem­
perature. These were diluted to 10 pg and 100 yg per ml in 
antigen dilution medium. These were prepared just prior to 
assembling the Mackaness chambers. 
Macrophage Migration Inhibition Factor (MIF) Tests : Guinea 
pig macrophages were added to the human leukocytes so that 
the ratio of guinea pig cells to human leukocytes was 
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approximately 3 to 2. Micro-hematocrit capillary tubes were 
filled two-thirds with the suspension of human and guinea pig 
cells (approximately 4 x 10^ total cells per tube). The 
tubes were sealed at one end by melting over a micro-burner, 
and then centrifuged at 55xg, 4°C for 10 min to pack the 
cells. Tubes were cut at the interface between the packed 
cells and supernatant portion. The packed tubes were attach­
ed by the sealed end with grease to the bottom slide in five 
sterile mackaness chambers. The chambers were closed, each 
filled with one of the antigen dilutions and one with the 
dilution media without antigen. They were then incubated at 
37°C, and read after 20 h. If possible, four hemotocrit 
tubes were used at each dilution, 
Reading MIF Tests : After incubation for 20 h, the pattern 
of cell migration from the tubes was enlarged on a Simmon 
Omega Model D-2 enlarger with Wollensak 50 mm enlarging 
raptur, traced on Artesian Bond paper, and the pattern was 
cut out and weighed on a Mettler H20T balance. The area 
(weight) of cell migration, when incubated with no antigen, 
was designated as 1.00. Areas of migration, for cells incu­
bated with antigens, were expressed as a decimal fraction of 
migration when incubated with no antigen. Such decimal frac­
tion was thereafter designated as an index of migration. 
Therefore, if cells migrated 25% less when incubated with 
antigen, the index of migration would be expressed as 0.75. 
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Statistical Analysis 
The Wilcoxon T-test (42) and 2-sample t-test (8) were 
used to determine whether the sample of patients and sample 
of negative controls had been drawn from different popula­
tions (with regards to cell migration indices, or with re­
gards to ratios of indices). Both statistical tests were 
performed, as a double check. Results of the analysis indi­
cated similar levels of significance, so only one value of 
significance will be reported. 
The 2-sample t-test may be used to compute a value of 
t by the following equation: 
_P - C 
t = 
where P and C are the mean values of patients and controls 
2 2 respectively: and are variance values of patients and 
controls, and; n and n are the number of individuals in 
P c 
the sample of patients and controls. The computed t may be 
interpreted for levels of significance from table a of t 
values. 
The Wilcoxon T-test was used in the case that there may 
not be a normal distribution of data values (an assumption 
made when using the above 2-sample t-test). Data from 
patients and controls were randomly paired, the differences 
between data values of paired subjects calculated, and the 
differences ranked according to be absolute value of the 
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difference. The ranks were assigned + or - values according 
to whether the difference between paired subjects was + or -. 
The value of T was the summation of the + or - ranks (which­
ever was least), and significance levels interpreted from an 
appropriate T table. 
CHAPTER III 
RESULTS 
GC Growth Curve ; In order to obtain the optimal ribosome 
yield from each culture of bacteria, it was necessary to 
determine when they would be in the middle or late exponen­
tial phase of growth. Cultures were therefore harvested at 
24 h intervals, and an approximate growth curve was plotted 
(Fig. 1). Results from the growth curve, confirming tradi­
tion, indicated 4 8 h cultures to be at log phase of growth 
and the optimal time to harvest. During log phase, the bac­
teria are synthesizing protein rapidly and will have high 
yields of ribosomes. 
It was observed that 72 h cultures were often difficult 
to subculture, indicating late log or death phase. During 
such phases, autolysis and ribonuclease destruction of the 
ribosomes would be maximal, and ribosomes isolated from those 
cultures would be damaged. Therefore, all cultures were 
harvested at 48 h. 
Sedimentation Velocity Determinations : Subsequent to crude 
ribosome isolation it was necessary to examine the prepara­
tion so that I could discover the nature of its constituents. 
Without such examination it cannot be defined as a ''ribosome" 
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Fig. 1. Growth curve of N. gonorrhoeae in modified T-M broth. 
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preparation. Therefore, analytical sedimentation velocity 
ultrocentrifugation was performed to determine the purity and 
sedimentation coefficient (5) of constituents present (Fig. 
2 )  .  
Schlieren optics provided an indication of the sample 
present within the centrifuge cell. Reading the photographs 
from left to right, one notices three distinct peaks emerging 
in the first frame. The sedimentation coefficient for each 
peak was determined by the rate that each peak moves down 
the cell. The first peak (left) had a sedimentation coeffi­
cient of 24.3, second 48.2, and third 66.3. These values can 
be extrapolated to 30S, 50S, and 70S at zero concentration, 
revealing that the preparation does contain ribosomes with­
out any other cellular constituents at major concentration. 
The amplitudes of the peaks are a reflection of the con­
centrations of each constituent. Apparently most of the 70S 
ribosomes were dissociated into constituent subunits within 
the buffer, because the 30S and SOS peaks represent the 
major portion of the ribosomal concentration. This sample 
was the only sample used for MIF tests performed in which 
crude ribosomes were tested with antigen. 
Bioassays: LPS contamination of ribosome preparations is an 
inevitable result of ribosome isolation from gram-negative 
bacteria. It was therefore necessary to assay for the endo­
toxin level within the crude ribosome preparation. Such 
determination would aid in interpreting whether ribosomes or 
Schlieren Optics of GC Crude Ribosomes 
used in CMI studies 
(4.8 itig/ml) 
Bar angle 70° 
6 min 4 min 2 min 0 min 
to 
m 
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LPS were the antigen within the crude ribosome preparation 
responsible for results obtained in the CMI studies. 
Limulus amebocyte lysate (LAL) tests were performed with 
the crude ribosome and LPS preparations. The clotting end-
point for GC LPS and GC crude ribosomes was 10^ ng/ml (Table 
1). Although both LPS and crude ribosomes had equivalent 
endpoints in this test, it was not conclusive that they had 
equivalent levels of endotoxin. Since the decrement of each 
dilution tested was by 10-fold, the endpoint dilution of one 
preparation may contain as much as nine times more endotoxin 
than the other preparation. 
Another possible limitation of the LAL test is its 
specificity. Researchers have demonstrated in studies with 
various blood plasma factors that the LAL test will react 
positively and clot with nucleoprotein (25). This suggested 
that the LAL may have been reacting with the ribonucleopro-
tein of the ribosomes. Because the endotoxin level in the 
crude ribosomes was to be so important in interpretation of 
the MIF results, we employed other tests of endotoxic acti­
vity to further quantify the endotoxin present. 
Chick Embryo LD^^ tests were performed as a measure of 
endotoxic activity for both the LPS and crude ribosome pre­
parations (Table 2). CELD^^ doses calculated by the method 
of Irwin and Cheeseman (41) yielded CELD^^ of 5.3 yg for the 
GC LPS and a CELD^q of 2.0 yg for the GC crude ribosomes. 
Five-fold dilutions were used in performing this test, so 
Table 1. Clotting reactions to limulus amebocyte 
lysale (LAL) of bacterial preparations. 
Concentration 
(ng/ml) Bacterial Preparation 
E. 
coli 
LPS 
GC 
LPS 
GC 
crude 
Ribosomes 
10 = ND + + 
10^ + + + 
10^ ND + + 
10^ + - -
10 ND - -
1 - - -
0.1 - - -
+ = clotting after incubation at 37°C 
- = no clotting after incubation at 37°C 
ND = not done 
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Table 2. Chick embryo responses to injection of GC LPS or 
GC crude ribosomes, and determination of Chick Embryo LD-q 
(CELD^Q). 
Dose 
(yg) 
Number 
inoculated Live 
GC 
LPS 
Hem Dead 
Crude 
Live 
GC 
Ribosomes 
Hem Dead 
0.0032 10 10 0 10 0 
0.016 10 10 0 10 0 
0.08 10 9 1 10 0 
0.4 10 10 0 10 0 
2.0 10 9 1 5 5 
10.0 10 2 8 0 10 
CELD50 
5.3 yg 
* 
2.0 ug 
Hem = hemorrhage 
* = as determined by the method of Irwin and Cheeseman (41). 
3 0 
that there is room for error. The test results, indicate the 
crude ribosomes to contain more than twice the endotoxic 
activity of the LPS preparation. 
Rabbit pyrogen tests were employed as the third test of 
the preparations for endotoxin. Milner and Finkelstein (57) 
have presented evidence that CELD^^ and pyrogen FI^q are 
measures of the same biological substance, therefore in in­
terpretation of rabbit pytogen tests similar to CELD^Q is 
applicable. There is no significant difference between the 
FI^q of the LPS and crude ribosomes, (Table 3) that for LPS 
being 17 ug and that for crude ribosomes being 21 pg (Fig. 3). 
Again, 5-fold dilutions were utilized in execution of the 
test, so that either preparation may contain four times as 
much endotoxin as the other. As with the CELD^q tests, endo­
toxin pyrogenicity of the crude ribosome preparation may have 
been amplified by ribosome presence in the mixture. 
The quality or form of febrile response in the pyrogen 
tests contributes additional information about the prepara­
tions, Classically, endotoxin will induce a biphasic re­
sponse in rabbits (46). That is, there will be an early 
febrile response followed by a drop, then another rise in 
temperature. This type of response occurs only with endo­
toxin injection, and can be used to determine whether the 
febrile response is induced by endotoxin or other substances. 
The febrile responses induced by our GC LPS and GC crude 
ribosomes were biphasic. Therefore, endotoxin in the 
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Table 3. Average rabbit fever response indices to i.v. 
injection of GC LSP or GC crude ribosomes. 
Dose 
(ug) 
GC 
LPS 
Average Fever 
Index (cm2) 
Dose 
(pg) 
GC 
Crude ribosomes 
Average Fever 
Index (cm2) 
0.4 6.4 0 . 6 2 5  15.2 
2.0 21. 8 2.5 18.0 
M
 o
 
o
 
28.1 10.0 33.2 
50. 0 50.8 40.0 45.6 
F:40* F:40. 
17 pg 21 pg 
* = as determined by the method of Keene et al. (46). 
Fig. 3. Average rabbit fever response indices to i.v. injection of GC LPS or GC crude 
ribosomes - determination of FI^^. Q/ 
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preparations was the moiety responsible for inducing the 
fever (Fig. 4). 
All three endotoxin tests gave the same results. This 
demonstrates similar levels of endotoxic activity for both 
preparations. It was therefore necessary to compare MIF 
tests responses to equal concentrations of each preparation. 
The reason for a comparison of responses to both preparations 
is to determine whether it is endotoxin or ribosomes within 
the crude ribosomes that is the agent responsible for re­
sults obtained. If the crude ribosome preparation (in con­
centration equal to the LPS preparation) causes a greater 
reaction (more migration inhibition) in the MIF system than 
does the LPS preparation, then a moiety other than endotoxin 
in the crude ribosome preparation is the responsible antigen. 
In Vitro CMI Studies : The area of migration of cells without 
antigen was designated as 1.00. Areas of migration with GC 
crude ribosomes or GC LPS as antigen were expressed as an 
index in relation to the area of migration without antigen. 
An index of migration of 0.60 indicates cell migration 60% 
of that without antigen; or, in other words, 40% inhibition 
of migration. The area of migration designated as 1.00 was 
determined for each subject due to difference in cell migra­
tion between tests by using macrophages from different indi­
vidual guinea pigs. Such differences were usually less than 
20% between tests. 
Fig. 4. Representative biphasic rabbit febrile response to i.v. injecfcion of endotoxin. 
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It was necessary to compare responses of lymphocytes 
from patients and control persons to GC LPS and GC crude ri-
bosomes in establishing criteria by which samples would be 
diagnosed as positive or negative. That is, the index of 
migration using GC crude ribosomes as antigen was compared 
to the index using GC LPS as antigen. 
Concentrations of antigen ranging from 1 to 200 yg were 
used at various times in search of a reliable concentration. 
Responses to 10 pg crude ribosomes were inconsistent (Table 
4). Of nine patients sampled, four did not respond with in­
hibition of more than 20%. Therefore, 10 wg crude ribosomes 
was rejected as a reliable concentration for diagnosis. One 
hundred yg of antigen elicited consistent responses by cells 
from patients and from control subjects (Table 4). 
Tradition dictates 20% inhibition, or 0.80 index of 
migration as the threshold response for a positive diagnosis 
(37). Samples with areas of migration less than 0.80 would 
therefore be diagnosed as positive. Such a straightforward 
diagnosis scheme would be applicable to this model if the 
inhibition of cell migration were entirely due to cell-
mediated immunity. But, as mentioned earlier, the crude 
ribosome preparation may be contaminated with homologous LPS 
during isolation, and monocytes may respond in peculiar ways 
to the presence of endotoxin (52). Therefore the endotoxin 
contamination may mimic a CMI response in the MIP test. This 
can be witnessed by observing indices of migration for both 
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Table 4. MIF test responses of culture positive persons 
tested on the first day of drug therapy. 
Migration Index **** 
GC Crude ** *** 
Ribosomes GC LPS Index Interpre-
Patient 10 yg 100 pg 10 yg 100 yg Ratio tation 
6 0.40* 0.34 ND ND — Pos 
7 0.52* 0.59 ND ND - Pos 
9 0.87* 0.79 ND ND — Pos 
10 0.78 0.75 1.20 0.94 0.80 Pos 
12 1.31 0.63 0.75 0.64 0.99 7 
13 0.90 0.60 0.82 1.00 0.60 Pos 
14 0.53 0.57 0.95 0.84 0. 68 Pos 
15 0.71 0.86 0.76 0.69 1.24 Nea 
16 0.80 0.65 0.77 0.88 0.76 Pos 
ND = not done. 
* = 20 g instead of 10 g were used. 
** = ratio of indices with 100 yg crude ribosomes to 100 yg 
LPS. 
*** = migration <0.80 with 100 yg crude ribosomes and ratio 
of indices <1.00 as criteria for positive. 
**** = migration index defined as the area of migration with 
antigen expressed as a decimal fraction of the area of migra­
tion without antigen. 
? - no interpretation made, because values were not defi­
nitely positive or negative. 
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patients and controls when their cells were incubated with 
100 yg GC crude ribosomes. If we use only the 0.80 criteria, 
8 of 9 patients responded with positive diagnosis, but 4 out 
of 9 controls also responded with migration inhibited by 
more than 20% (Table 5) -- i.e., there were 44% false posi­
tive diagnosis. 
It was therefore necessary to establish an extra cri­
terion which would take into account the presence of LPS con­
tamination. As demonstrated in the above bioassays, 10 0 pg 
crude ribosomes and 100 pg LPS exhibited approximately equal 
endotoxicity. Cells which are inhibited from migrating more 
by the crude ribosomes than the LPS can be said to be sensi­
tive to a factor other than, or in addition to, LPS in the 
crude ribosomes preparation — i.e., ribosomes. We therefore 
established the second criterion, that the migration index 
of cells incubated with crude ribosomes be less than the 
index of the cells with LPS. 
Five of the 6 GC patient cells tested with both 100 pg 
LPS and 100 pg crude ribosomes responded more to the crude 
ribosome preparation than to the LPS. Even more significant 
was the demonstration that, of the four false positive by 
the 0.80 criterion alone, three were interpreted as negative 
by this additional criterion. In other words, only 1 of the 
9 controls (11%) remained a false positive when both cri­
teria were employed — the only false positive being patient 
7. 
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Table 5. MIF test responses of gonococcal negative control 
sub]ects. 
Migration Index *** 
Control 
GC Crude 
Ribosomes 
10 yg 100 ug 
GC 
10 ng 
LPS 
100 pg 
** 
Index 
Ratio 
** *  
Interpre­
tation 
1 0.71* 1.40 ND ND - Neg 
2 ND 1.00 ND ND — Neg 
3 0.79 1.23 0.60 0.61 2.00 Neg 
4 0 .80 0.69 0.62 0.41 1.68 Neg 
5 1. 05 0.91 1.08 0.79 1.15 Neg 
6 0.74 0. 65 0.82 0.58 1.12 Neg 
7 1.50 0.79 0 . 9 3  1.16 0.68 Pos 
8 1.91 1.51 1.93 1.71 0 . 88 Neg 
9 0. 90 0.74 0.74 0.56 1.20 Neg 
ND = not done. 
* - 20 pg instead of 10 ijg were used. 
** = ratio of indices with 100 yg crude ribosomes to 100 pg 
LPS. 
*** = migration <0.80 with 100 yg crude ribosomes and ratio 
of indices <1,00 as criteria for positive. 
**** - migration index defined as the area of migration with 
antigen expressed as a decimal fraction of the area of migra­
tion without antigen. 
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Diagnosis of all subjects was therefore made on the 
basis of two criteria for positive interpretation: 1) migra­
tion with 100 yg ribosomes must be less than 0.80, and 2) the 
ratio of the indices for 100 pg crude ribosomes to 100 yg LPS 
be less than 1.00. When these two criteria were used, there 
was 78% correct diagnosis of GC culture positive individuals, 
and an 11% rate of false positivity. Diagnosis of GC culture 
positive persons was actually 89% correct, when we adhere 
strictly to the criteria. But, because data from patient 
12 was on the threshold of positivity, we interpreted him as 
neither positive nor negative. 
Comparison and statistical analysis of differences be­
tween patient and control indices of migration to 100 yg GC 
crude ribosomes (Tables 4 and 5) indicates a level of signi­
ficance of p <0.03. A similar analysis of the differences 
between the index ratios of patients and controls (Tables 4 
and 5) indicates a level of significance of p <0.13. 
Persons with stimulated cell-mediated immune systems 
were examined to determine what cross reactivity may occur 
(Table 6). Because mycobacterial infection and vaccination 
stimulates CMI, persons vaccinated with M. bovis strain BCG 
were examined. Despite a small sampling, various observa­
tions can be made First of all, lymphocytes from these 
persons responded vigorously to both the LPS and crude ribo-
somal preparations. This is evidenced by migration indices 
well below 0.80. Secondly, because the ratio of the indices 
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Table 6. MIF test responses of subjects immunized with BCG. 
Migration Index * * * * 
GC Crude * * * * * 
Ribosomes GC LPS Index Interpre­
Person 10 yg 109 yg 10 yg 100 yg Ratio tation 
1 0.65 0.29 ND ND Pos 
2 0.54 0.62 0.59 0.30 2.05 Neg 
3 0.56 0.28 0.41 0 . 2 6  1. 0 3 Neg 
ND - not done. 
* = 20 pg instead of 10 yg were used. 
** = ratio of indices with 100 ug crude ribosomes to 100 pg 
LPS. 
*** = migration <0.80 with 100 yg crude ribosomes and ratio 
of indices <1.00 as criteria for positive. 
**** = migration index defined as the area of migration with 
antigan expressed as a decimal fraction of the area of migra­
tion without antigen. 
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was above 1.00, 2 of the 3 persons samples were diagnosed as 
negative. The other was not tested against LPS, so that a 
ratio of indices was not established. 
Characterization of CMI to GC infection entails examin­
ation of both inception and termination of the response. 
Therefore, this investigation monitored patient responses to 
the MIF test at various intervals post-therapy (Table 7). 
Again, because of differences in degree of sensitization, we 
expected and found varied lengths of sensitization. The only 
patients tested at one week post-therapy, patients 2 and 3, 
were still sensitive by our established criteria, and simi­
larly, at six weeks, patient 5 had retained sensitivity to 
the antigen. 
Eight weeks appears to be somewhat of a threshold for 
retention of sensitivity; patient 1 had converted to nega­
tive. Other negative diagnoses were found for patient 1 
tested 10 weeks post-therapy and patients 4, 8, and 10 tested 
at 16 weeks post-therapy. Patient 5 remained strongly posi­
tive even 20 weeks post-therapy. It appears that 8 to 16 
weeks post-therapy may be the threshold for reversion to neg­
ative . 
Based upon statements concerning duration of infection 
prior to treatment and MIF testing (Table 8), it was ob­
served that even patients who contacted the disease 7-10 days 
before testing, responded positively (patients 2, 3, and 6). 
It may therefore be inferred that within 10 days after 
Table 7. MIF test responses of culture positive persons tested on the first day 
of drug therapy, and at various intervals post-therapy. 
Time Migration Index **** 
after 
therapy * * * * * 
when GC Crude Ribosomes GC LPS Index Interpre­
Patient tested 10 yg 100 yg .10 yg 100 yg Ratio tation 
1 0 0.53* 0.20 ND ND - Pos 
8 wk 0.69 0.65 0.75 0.52 1.25 Ne g 
20 wk 0.78 0.82 0.59 0.89 0.92 Neg 
2 0 0.96* 0.41 MD ND - Pos 
1 wk 0.58* 0.34 ND ND - Pos 
3 0 0.13* 0.08 ND ND - Pos 
1 wk 0.75* 0.33 ND ND - Pos 
4 0 0.93* 0.60 ND ND -, Pos 
16 wk 1.12 1.30 1.37 1.18 
o
 
1—1 •H 
, Neg 
5 0 0.71* 0.50 ND ND - Pos 
6 wk 1.05 0.56 0.80 0.96 0.58 Pos 
20 wk 0.72 0.58 0.50 0.61 0.95 Pos 
8 0 0.58* 0.72 ND ND - Pos 
16 wlc 0. 57 1.29 0.94 1.20 1.07 Neg 
10 0 0.78 0.75 1.20 0.94 0.80 Pos 
16 wk 0.92 0.81 0.78 0.76 1.06 Neg 
wk = weeks. 
ND = not done. 
* = 20 ug instead of 10 yg were used. 
** = ratio of indices with 100 pg crude ribosomes to 100 yg LPS. 
*** = migration <0.80 with 100 yg crude ribosomes and ratio of indices <1.00 as 
criteria for positive. 
**** = Migration index defined as the area of migration with antigen expressed as 
a decimal fraction of the area of migration without antigen. 
K) 
Table 8. Medical histories of all patients tested. 
Patient Sex Age 
Estimated 
Duration 
Prior to Testing Clinical 
Venereal Disease 
History 
1 F 19 2 months Symp None 
2 F 19 10 days Asymp None 
3 M 20 10 days Symp June 75(Trichuria) 
4 F 21 6 weeks Asymp None 
5 F 24 NA Symp NA 
6 M 23 1 week NA NA 
7 M 20 NA Symp July 75 (GC) 
8 F 19 5 months Asymp None 
9 F 20 1 month NA None 
10 F 20 NA Symp None 
12 F 19 12 months Asymp None 
13 M 27 NA Symp NA 
14 M 17 NA Symp None 
15 M 20 2 weeks Asymp None 
16 M 24 NA Symp NA 
Symp = symptomatic 
Asymp = asymptomatic 
NA = not available 
A. 
CrJ 
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gonococcal contact, sensitization takes place. Patient 15 
failed to respond with positive diagnosis with MIF testing 
two weeks post-contact. Therefore, the period of time before 
sensitization takes place, as well as the period of time be­
fore sensitization ceases, is a variable of individual dif­
ferences of infection. 
Cumulative MIF Test Response Results ; The control group had 
an average migration index of 0.99 when incubated with 100 yg 
crude ribosomes (Fig. 5). The GC culture-positive group, on 
the other hand, responded to 100 yg crude ribosomes with an 
average migration index of 0.55 — i.e., 45% inhibition of 
migration. Although there was a distinct difference between 
the two groups of subjects, when cells were incubated with 
100 yg crude ribosomes, they responded equally to 100 yg LPS 
-- i.e., an average index of 0.8 3 for each group. The BCG 
immunized group responded significantly to both crude ribo­
somes and LPS. However, unlike the GC culture-positives, 
the BCG group responded more to 100 yg LPS than to 100 yg 
crude ribosomes. 
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Fig. 5. Cumulative averages of MIF test responses to 100 ug GC 
crude ribosomes or 100 ug GC LPS. Migration index is the area 
of migration with antigen expressed as a decimal fraction of 
migration without antigen. Bars represent the ranges of responses. 
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CHAPTER IV 
DISCUSSION 
In the present study, CMI of gonorrhea patients to 
a gonococcal crude ribosome preparation was demonstrated in 
vitro. Statistical analysis of the data indicated a signi­
ficant (p <0.02) difference in the level of responses be­
tween lymphocytes from patients and control subjects. Pre­
vious to the present investigation, studies of lymphocyte 
transformation ̂  vitro had been used to demonstrate CMI 
against N. gonorrhoeae protoplasm preparations (27, 31, 49). 
Grimble and Mclllmurray (31) observed positive responses with 
lymphocytes from 10 of 12 patients studied, but they also 
noted that lymphocytes from 4 of 10 control subjects gave 
false positive responses. 
In the present study, 20% inhibition of migration was 
used as the threshold for a positive response, and 8 of 9 
patients gave positive responses. However, 4 of 9 uninfec­
ted controls also had such responses. It was considered 
that the positive responders were sensitized to some moiety 
within the crude ribosome preparation. Alternatively, some­
thing within the preparation may have caused lymphocytes to 
mimic CMI when incubated with it. Because crude ribosomes 
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might have been contaminated with LPS during their isolation, 
it was decided to test an LPS preparation (with endotoxicity 
equal to that of the crude ribosomes) in parallel with the 
crude ribosome preparation. When incubated with GC LPS, 
lymphocytes from infected patients and from uninfected con­
trol subjects nonspecifically inhibited migration of guinea 
pig macrophages. Others have reported that LPS might inhibit 
migration in MIF tests (34). This raised the question of 
whether or not LPS within the crude ribosome preparation was 
responsible for the migration inhibition observed. It was 
noted that lymphocytes from infected patients responded with 
more migration inhibition to the crude ribosome preparation 
than they did to the LPS preparation, whereas lymphocytes 
from uninfected controls did not respond more to the crude 
ribosome preparation than to the LPS preparation (p <0.13). 
Because the antigenic preparations of Grimble and Mclllmurray 
(31), and of others (27, 49) were ill-defined, moieties act­
ing as nonspecific mitogens may have been present within 
their preparations, and were responsible for eliciting the 
high rate of false positives. 
There appears to be some question as to the nature of 
the antigen, within the crude ribosome preparation, which was 
indicating the patient's sensitivity; i.e., what moiety was 
the agent to which lymphocytes from GC patients had become 
sensitized? Several possibilities were considered: 
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1) In the present study, incubation of lymphocytes with 
the LPS preparation and with the crude ribosomes preparation 
did not give similar responses, therefore LPS could not have 
been the antigen. Although LPS was not the specific antigen, 
it might have played a role as a molecular carrier of the 
antigenic determinant. 
2) Was nascent protein, which was being synthesized on 
the ribosomes, the specific antigen within the crude ribo-
some preparation? Most of the nascent protein was probably 
removed during ribosome isolation. Photographs of Schlieren 
patterns of the crude ribosome preparation illustrated that 
the ribosomes had dissociated into 30S and 50S subunits, and 
therefore would have released any nascent protein (36). When 
the ribosomes were centrifuged, the nascent protein would 
have remained in the supernatant fluid and would have been 
discarded. Any homogeneous nascent protein which did remain 
would have been in such low concentration that it is very 
unlikely to have been the specific antigen in the crude ribo­
some preparation. 
3) Buchanan et a^. (13) have demonstrated that pilin or 
pili could be used as a specific antigan for seo-testing. Is 
it possible that this gonococcal protein was contained within 
the crude ribosome preparation and was responsible for CMI 
results obtained? Individual pilin molecules, as well as 
pili, were probably eliminated in the same manner as was 
nascent protein, since their sedimentation coefficient would 
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be very low. This is verified by lack of perturbation in 
the baseline of the Schlieren photographs of the GC crude 
ribosomes. Therefore, pilin and pili may be eliminated from 
consideration as the antigen responsible for specific migra­
tion inhibition observed. 
4) Esquenazi and Streitfeld (27), Grimle and Mclll-
murray (31) , and Kraus et (4 9) prepared an antigen of 
sedimented protoplasm extracts of the gonococcus. Entities 
with sedimentation properties similar to those of the crude 
ribosomes must have been contained in their antigenic prepa­
rations. The ribosomal material which I employed was a 
better prepared and defined preparation than a simple proto­
plasmic extract. Methods used for preparation of the 
ribosomes eliminated many soluble cytoplasmic factors con­
tained in the other preparations. 
5) Since patients with gonorrhea do mount an immuno­
logical response to several GC antigens (3, 11, 38, 500, 51, 
71, 83), it was necessary to utilize an antigen in CMI or 
sero-testing which will best demonstrate specific sensitivity. 
Ribosomes make up 25% of the total cellular mass of some 
kinds of bacterial cells (85), and therefore ribosome struc­
tural proteins are immunogens which would be generally 
plentiful, and which might elicit sensitization during 
infection. Therefore, ribosome structural proteins provide 
a high level of homogeneous protein to which immunocompetent 
cells may become sensitized. Although ribosome structural 
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proteins have not been proven to contain the antigenic 
determinant responsible for the MIF test results, they are 
implicated as the antigen. 
In this investigation, a preparation which contained GC 
ribosomes was used as an antigen. Although only a pilot 
study, the study did demonstrate that gonorrhea patients can 
become specifically sensitized to a moiety within a gonococ­
cal crude ribosome preparation. 
Attempts to develop an immuno-diagnostic test for de­
tection of gonorrhea have been confronted with difficulties 
in detecting sensitization, either humoral or cell-mediated. 
This project encountered similar problems. In order to 
detect consistently CMI against the crude ribosome prepara­
tion, it was necessary to use ribosomal concentrations of 
100 yg/ml. There are various possible explanations for the 
need of a high antigen concentration in detecting sensitiza­
tion. One problem may have been the possible degradation of 
the antigen used in the test. The GC were killed by pouring 
fresh cells over ice and holding them at 4°C overnight. 
Although the cold would retard enzymatic autolysis, it would 
not stop it completely. Many of the antigens might have 
been degraded, therefore, although 10 0 yg/ml of the final 
preparation was used, only a fraction of it could have been 
of specific, intact antigen. 
Another possible explanation for difficulty in detecting 
sensitization might have been that there was a very low level 
51 
of sensitization in the infected patients. There are several 
possible mechanisms for the failure of the patients to de­
velop sensitization. First, the immunogens could have been 
autolyzed during infection before immunocompetent cells were 
able to process them. Second, since gonorrhea is a superfi­
cial infection, relatively isolated from the immune system, 
immunocompetent cells might have only infrequently reached 
the immunogens for sensitization. 
The time factor involved in sensitization is worthy of 
note. Esquenazi and Streitfeld (27) have reported that lym­
phocytes from gonococcal patients responded to various 
gonococcal sonicates with blastogenesis ̂  vitro. They dem­
onstrated sensitization 5 days after gonococcal contact and 
cessation of sensitivity 5 weeks after therapy was begun. 
Within the limitations set by sampling, results herein paral­
leled theirs; i.e., sensitization to the gonococcal crude 
ribosome preparation was demonstrated to begin approximately 
7 days after contact, and sensitivity was observed to cease 
8 to 16 weeks post-therapy. Data obtained from a single 
patient (#5) indicated that delayed hypersensitivity was 
present as long as 20 weeks post-therapy. Since GC cannot be 
cultured from urogenital areas of patients 2 days after suc­
cessful antibiotic treatment (54), viable GC were probably 
cleared from the system. If patient 5 had been cured, the 
immunogens should have been cleared and the patient would 
have returned to negative diagnosis. Because of the high 
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level of sensitivity remaining at 20 weeks in patient 5, 
this suggests active infection. Though generally effective, 
treatment does not result in cures in all cases. Most re­
searchers define as successful a 95% cure rate (depending on 
the program and type of drug therapy used) (55, 77). Since 
subjects were tested on a voluntary basis, the laboratory 
was unable to examine patient 5 to see whether she had been 
cured of the infection. 
The amount of stimulus necessary to elicit demonstrable 
sensitization requires mention. Kraus et a]^. (50) have re­
ported that a sequence of two infections was required before 
CMI could be detected. The present studies were able to 
detect a CMI response in most of the patients after a single 
infection. Two possible reasons are evident for this dif­
ference. Either, 1) MIF testing is a more sensitive test 
than is blastogenesis for detecting CMI to N. gonorrhoeae 
infection, or 2) The antigenic preparation contained an 
antigenic determinant which detects sensitization better than 
did the preparation used by Kraus. 
The MIF test employed to demonstrate CMI is a very te­
dious procedure. MIF testing, therefore, is not suggested 
as a diagnostic methodology to screen populations for GC in­
fection. However, results of this ̂  vitro study demonstrate 
the potential fruitfulness of studying various moieties from 
the GC crude ribosome preparation as ̂  vivo skin test anti­
gens. Such a test, if developed, would provide an ideal 
diagnostic aid in detecting and treating the reservoir of 
infections, thereby reducing and maintianing gonococcal in 
fection at reasonable levels. 
CHAPTER V 
SUMMARY 
The purpose of this investigation was to determine 
whether cell-mediated immunity (CMI) could be demonstrated 
to gonococcal crude ribosomes. As the investigation evolved, 
it was necessary to consider factors within the crude ribo­
somes, which had been isolated by differential ultracentri-
fugation, that may lead to nonspecific responses to endotoxin 
present. 
In MIF tests lymphocytes from patients with gonorrhea 
were found to respond significantly more than did lympho­
cytes from negative control subjects when incubated with GC 
crude ribosomes. This indicated that persons infected with 
GC were sensitized to a moiety within the crude ribosome 
preparation. Bioassays failed to distinguish crude ribosomes 
from LPS in terms of endotoxicity. To correct the results 
for effects of LPS within the crude ribosomes, lymphocytes 
were also incubated in MIF tests with concentrations of LPS 
equal to that present in the crude ribosomes. It was ob­
served that GC LPS nonspecifically induces lymphocytes from 
patients, controls, and BCG vaccinated persons to inhibit 
guinea pig macrophage migration. Crude ribosomes, on the 
other hand, specifically inhibit guinea pig macrophages 
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incubated with lymphocytes of patients with gonorrhea. Based 
upon lymphocyte responses to the two gonococcal preparations, 
correct diagnosis of 7 of 9 infected patients and 8 of 9 
negative controls was made. 
Using criteria established from lymphocyte responses to 
the two preparations, several patients were tested at various 
intervals post-therapy. Based upon these follow-up studies 
and medical histories it was determined that sensitization 
was established within 2 weeks of the contraction of infec­
tion, and it subsided 8 to 16 weeks post-therapy. 
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